GSK
778 hedge funds and large institutions have $9.9B invested in GSK in 2017 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 281 increasing their positions, 267 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.13% more ownership
Funds ownership: 3.6% → 3.73% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
1% less funds holding
Funds holding: 785 → 778 (-7)
Holders
778
Holding in Top 10
11
Calls
$142M
Puts
$72.1M
Top Buyers
| 1 | +$213M | |
| 2 | +$120M | |
| 3 | +$100M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$59.9M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$35.9M |
Top Sellers
| 1 | -$251M | |
| 2 | -$85.5M | |
| 3 | -$22.5M | |
| 4 |
Goldman Sachs
New York
|
-$19.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.1M |